FDA Inspection 1201702 — JW Pharmaceutical Corporation - Sihwa Plant
The FDA completed an inspection of JW Pharmaceutical Corporation - Sihwa Plant on March 17, 2023 in Siheung-Si. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 17, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Siheung-Si (Korea (the Republic of))